GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Mid-range Performer
2767.4000 6.40 (0.23%)
NSE Oct 10, 2025 15:31 PM
Volume: 39,058
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
02 Aug 2025
2767.40
0.23%
buy
by Motilal Oswal
Target: 3000 | Upside : 8.4%
Motilal Oswal
GlaxoSmithKline Pharmaceuticals (GLXO) delivered lower-than-expected revenue/EBITDA (8%/5% miss) in 1QFY26.
 
Number of FII/FPI investors decreased from 390 to 362 in Sep 2025 qtr
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - October 10, 2025
The Baseline | 10 Oct 2025
Market closes higher, Capacit'e Infra bags Rs 542 cr order from IIT Bombay
Trendlyne Marketwatch | 10 Oct 2025
Clickbait has come for the Indian stock market
The Baseline | 10 Oct 2025